Federated Hermes’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.17K | Hold |
|
|||||
|
2024
Q3 | $1.63K | Hold |
|
|||||
|
2024
Q2 | $1.56K | Hold |
|
|||||
|
2024
Q1 | $1.17K | Hold |
|
|||||
|
2023
Q4 | $710 | Sell |
|
|||||
|
2023
Q3 | $998 | Sell |
|
|||||
|
2023
Q2 | $430K | Sell |
|
|||||
|
2023
Q1 | $1.34M | Buy |
|
|||||
|
2022
Q4 | $4.19M | Buy |
|
|||||
|
2022
Q3 | $2.68M | Buy |
|
|||||
|
2022
Q2 | $410K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $368K | Sell |
|
|||||
|
2021
Q2 | $374K | Sell |
|
|||||
|
2021
Q1 | $517K | Sell |
|
|||||
|
2020
Q4 | $442K | Sell |
|
|||||
|
2020
Q3 | $504K | Sell |
|
|||||
|
2020
Q2 | $1.04M | Sell |
|
|||||
|
2020
Q1 | $2.29M | Sell |
|
|||||
|
2019
Q4 | $22.1M | Sell |
|
|||||
|
2019
Q3 | $28.3M | Buy |
|
|||||
|
2019
Q2 | $235K | Sell |
|
|||||
|
2019
Q1 | $224K | Buy |
|
|||||
|
2018
Q4 | $213K | Sell |
|
|||||
|
2018
Q3 | $20.1M | Sell |
|
|||||
|
2018
Q2 | $16.1M | Sell |
|
|||||
|
2018
Q1 | $59.9M | Sell |
|
|||||
|
2017
Q4 | $76.4M | Buy |
|
|||||
|
2017
Q3 | $24.7M | Sell |
|
|||||
|
2017
Q2 | $21.5M | Buy |
|
|||||
|
2017
Q1 | $25.3M | Buy |
|
|||||
|
2016
Q4 | $12.6M | Hold |
|
|||||
|
2016
Q3 | $17.6M | Sell |
|
|||||
|
2016
Q2 | $25.9M | Buy |
|
|||||
|
2016
Q1 | $24.7M | Sell |
|
|||||
|
2015
Q4 | $65.4M | Buy |
|
|||||
|
2015
Q3 | $39.3M | Buy |
|
|||||
|
2015
Q2 | $44.7M | Sell |
|
|||||
|
2015
Q1 | $46.7M | Sell |
|
|||||
|
2014
Q4 | $77.3M | Sell |
|
|||||
|
2014
Q3 | $70.9M | Sell |
|
|||||
|
2014
Q2 | $75.8M | Sell |
|
|||||
|
2014
Q1 | $77.4M | Buy |
|
|||||
|
2013
Q4 | $59.6M | Sell |
|
|||||
|
2013
Q3 | $56.4M | Sell |
|
|||||
|
2013
Q2 | $72.2M | Buy |
|